TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance

U.S. Markets open in 5 hrs 49 mins

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
37.04+0.51 (+1.40%)
At close: 4:03 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close36.53
Bid35.70 x 900
Ask35.76 x 2600
Day's Range36.40 - 37.18
52 Week Range36.40 - 66.55
Avg. Volume9,002,888
Market Cap37.6B
PE Ratio (TTM)21.55
Earnings DateN/A
Dividend & Yield1.36 (3.72%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire2 hours ago

    Teva Receives Positive Outcome for COPAXONE® Label in Europe

    Teva Pharmaceutical Industries Ltd. today announced that it has received a positive outcome through the variation procedure to remove the pregnancy contraindication from the European label for COPAXONE® 20 mg/mL.

  • TherapeuticsMD Soars On Positive Menopause Drug Trial Results
    Investor's Business Daily10 hours ago

    TherapeuticsMD Soars On Positive Menopause Drug Trial Results

    TherapeuticsMD surged late Monday after saying that its menopause drug reduced hot flashes and other vasomotor symptoms in a late-stage trial.

  • Reuters10 hours ago

    Teva names Bhattacharjee as generics group head, replacing Olafsson

    Teva Pharmaceutical Industries , the world's biggest generic drugmaker, has appointed Dipankar Bhattacharjee as chief executive for its global generic medicines group, replacing Siggi Olafsson. Bhattacharjee, who has served as CEO of Teva Generics Europe since April 2013, will replace Olafsson, who will retire at the end of the first quarter of 2017. Bhattacharjee will be based in the United States.